Crossmark

Arming the oncolytic virus enadenotucirev (EnAd) to generate enhanced locally-acting immunotherapies for cancer

Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P334

Published Online: 2015-11-04

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Champion, Brian R

Rasiah, Nalini

Illingworth, Sam

Calderon, Hugo

Besneux, Matthieu

Lear, Rochelle

Plumb, Darren

Kodialbail, Prithvi

Brown, Alice
More Information

Article History

First Online: 4 November 2015